56th Annual Meeting
Tentative Program Schedule
Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

Institute 1 (ticket)
Advanced Psychopharmacology Institute: Translating Recent Psychopharmacological Research Findings into Clinical Care

This Institute provides clinicians with an update on recent psychopharmacotherapy trials, accompanied by implications for clinical practice. The presentations include updates and discussions of pediatric psychopharmacology for the treatment of ADHD, autism, depression, psychosis, bipolar disorder, and anxiety disorders. Additional topics include monitoring and management of adverse effects, as well as clinically relevant information pertaining to pharmacokinetics. Recent literature is reviewed, with a particular emphasis placed on recent NIMH-funded multimodal clinical trials. Awareness of recent psychopharmacology research and the application of this information can inform and positively impact patient care.
Tuesday, October 28, 2008: 8:00 AM-5:00 PM
Sheraton Ballroom
Level 4
Sheraton Chicago Hotel & Towers
Melissa P. DelBello, M.D.
Christopher J. Kratochvil, M.D.
8:00 AM  
Welcome and Introduction
8:10 AM  
Psychopharmacology: Pharmacokinetics, Pharmacodynamics, and Pediatric Psychosis
Robert L. Findling, M.D. University Hospitals Case Medical Center, Cleveland, OH
9:05 AM  
Psychopharmacology of Pediatric Depressive Disorders
Karen Dineen Wagner, M.D., Ph.D. University of Texas Medical Branch, Galveston, TX
10:00 AM  
10:10 AM  
Recent Advances in the Treatment of Pediatric Anxiety Disorders
John T. Walkup, M.D. Johns Hopkins Hospital, Baltimore, MD
11:05 AM  
How Do Research Findings Influence Clinical Decision Making in the Treatment of ADHD?
Steven R. Pliszka, M.D. University of Texas Health Science Center at San Antonio, San Antonio, TX
12:00 PM  
Panel Q & A
12:30 PM  
Lunch (on your own)
1:30 PM  
Psychopharmacology of Autism and Other Pervasive Developmental Disorders
Christopher J. McDougle, M.D. Indiana University School of Medicine, Indianapolis, IN
2:25 PM  
2:35 PM  
Evidence-Based Treatments and Pharmacogenomics of Pediatric Bipolar Disorder
Robert A. Kowatch, M.D., Ph.D. Children's Hospital, Cincinnati, OH
3:30 PM  
Improving Outcomes through Adequate Monitoring and Management of Psychotropic Adverse Events in Children and Adolescents
Christoph U. Correll, M.D. Zucker Hillside Hospital, Glen Oaks, NY
4:30 PM  
Panel Q & A
See more of: Institute